TRAF6 and prostate carcinoma: Li et al. have also reported that resveratrol caused a therapeutic effect by inhibiting the viability, proliferation, and EMT of prostate cancer cells by reducing the level of TNF receptor-associated factor 6 (TRAF6) [167].